New CBIS Financial Security Department to Handle Security, Asset Pick up and Delivery and Payment Processing for the USA State by State and Worldwide Cannabis Industry
IRVINE, Calif., Sept. 2, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce the development and opening of the Cannabis Science Financial Security Department.
The creation of CBIS Security Department was critical. Staffing and training are crucial to CBIS, having the right staff to handle payment processing, security, and asset pick-up and delivery. These measures are essential in protecting the integrity of the dispensary and the clients it will serve. Since 9/11 the private sector of the security industry has seen about 143% growth without any decline in sight. Also an integral part of this team is Risk Mitigation, which evaluates footprint and impact. Then the team formulates the appropriate measures to reduce the footprint and impact but optimizes productivity and viability.
The company will implement the best training programs, evaluate and update standard operating procedures and will look to develop new technology that will put them a step ahead of their competitors. The company is forming relationships with financial institutions for account set-ups and payment processing and upon initiation of this department the company is targeting security of lab, site, grow, dispensary, pick-up and delivery and risk mitigation. These services CBIS provides will be readily available to All on a State by State and Worldwide bases.
The CBIS Security Team (CBISST)
The CBIS Security Team (CBISST) are subject matter experts in personnel protection, physical security, force protection, security systems design, crisis management, disaster preparedness, anti-terrorism planning, risk mitigation implementation and training.
The CBISST provides effects-based, real-world security and safety solutions for the cannabis industries financial, research lab, grow, site and dispensary security. CBISST also has the necessary training and follow-on logistics support for the customer, sites, cash-routes and transports. The company’s goal is to provide customers with the most effective and efficient integrated mixture of personnel safety, personal security, transport safety, transport security, manpower, tactics, techniques, procedures, and technology.
The CBIS Security Team provides effects-based, real-world security and safety solutions; specialists in Security/Anti-terrorism, effects-based, physical protection, system design, evaluation, and integration management. CBISST also has the necessary training and follow-on logistics support for the security systems.
As the company gears up to service the “CIT” (cash in transit) industry, there will be certain assets that the company will need to acquire in order to efficiently provide the best service possible. The company is planning to run 24/7 shifts and will require 7-12 uniformed officers in California. There will also be a logging /tracking system that keeps both parties accountable, also in use will be the company’s merchant credit card processing transaction report tracking.
“I am excited, yes I know I say that a lot, but this is yet again forward progress. Things feel like they are moving so quickly now, the labs, the school, the property and now security. With our Security Model we are ensured to run a professional and cost effective business. How can I not be ecstatic? We now have some of the most experienced security experts in the industry, this highly complements our ‘Sea to Shining Sea’ nationwide rollout,” stated Mr. Raymond C. Dabney, Cannabis Science, Inc. President & CEO, Co-Founder.
On the heels of announcing the Cannabis Science Cannabinoid-Based Asthma/COPD Treatment, CBIS continues to strive in their efforts in research and development. Our Risk Mitigation Specialist have identified a growing concern from the footprint from a research lab, a grow, a dispensary and sites. Our Specialized Team at CBIS has mitigated the risk and impact with real time solutions. Having all labs, grows, dispensaries and sites conform to these new rules and regulatory measures coupled with the appropriate safety protocols in place not only advances the company further but more importantly it reduces the footprint on the environment, populous and infrastructure.
About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of a unique understanding of biologic processes to provide novel treatment approaches for common ailments and for those disorders where current treatments are relatively unsuccessful and understanding remain incomplete. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the increasingly complex underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3051593